Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Antibody–drug conjugates

Breaking up is hard to do

Nature Chemical Biology volume 15, pages 934–935 (2019)Cite this article

Subjects

A comprehensive genetic screen reveals new cellular trafficking factors and linker-dependent requirements for antibody–drug conjugate (ADC) cytotoxicity. These new insights may guide the design of optimized ADCs.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Mechanisms for drug release from antibody–drug conjugates.

References

  1. Mukherjee, A. et al. Hum. Antibodies 27, 53–62 (2019).

    Article  CAS  Google Scholar 

  2. Coats, S.et al. Antibody-drug conjugates: future directions in clinical and translational strategies to improve the therapeutic index. Clin. Cancer Res. https://doi.org/10.1158/1078-0432.CCR-19-0272 (2019).

    Article  Google Scholar 

  3. Abdollahpour-Alitappeh, M. et al. J. Cell. Physiol. 234, 5628–5642 (2019).

    Article  CAS  Google Scholar 

  4. Tsui, C. K.et al. Nat. Chem. Biol. https://doi.org/10.1038/s41589-019-0342-2 (2019).

  5. Hamblett, K. J. et al. Cancer Res. 75, 5329–5340 (2015).

    Article  CAS  Google Scholar 

  6. Vaites, L. P., Paulo, J. A., Huttlin, E. L. & Harper, J. W. Mol. Cell. Biol. 38, e00392–17 (2017).

    Article  Google Scholar 

  7. Gébleux, R., Stringhini, M., Casanova, R., Soltermann, A. & Neri, D. Int. J. Cancer 140, 1670–1679 (2017).

    Article  Google Scholar 

  8. Kang, J. C. et al. Nat. Biotechnol. 37, 523–526 (2019).

    Article  CAS  Google Scholar 

  9. Chalouni, C. & Doll, S. J. Exp. Clin. Cancer Res. 37, 20 (2018).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Seattle Genetics, Bothell, WA, USA

    Heather A. Van Epps & Peter D. Senter

Authors
  1. Heather A. Van Epps
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter D. Senter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter D. Senter.

Ethics declarations

Competing interests

The authors are employees of Seattle Genetics, a company engaged in the field of antibody–drug conjugates.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Van Epps, H.A., Senter, P.D. Breaking up is hard to do. Nat Chem Biol 15, 934–935 (2019). https://doi.org/10.1038/s41589-019-0351-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41589-019-0351-1

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research